European Federation of Endocrine Societies |
 |
| January
2004 News Alert |
|
http://www.euro-endo.org |
| European
News |
|
Regulars |
| |
|
|
| |
| http://www.euro-endo.org/news.htm |
|
Now
you can submit to EJE online!
The European Journal of Endocrinology has launched online submission
and peer review, making it quicker and easier to submit your articles
to EJE. The ESPERE (electronic submission and peer review) system
enables authors to submit their articles as PDF files by registering
on the site at http://www.eje.org/eje/onlinesub.htm.
Users are given advice on creating their files and guided step-by-step
through the submission procedure.
Authors submitting
through ESPERE should benefit from more rapid publication than
with the paper-based system. In addition, they are able to view
the status of their manuscripts throughout the review process,
their submission history and can also submit additional files,
such as their revised manuscript.
More details
and submission instructions are available at http://www.eje.org/eje/onlinesub.htm
EFES
News - are you getting yours?
If you are a member of any of the European national endocrine
societies, you should receive a free copy of EFES News (http://www.euro-endo.org/news.htm)
each spring and autumn. If you are not receiving this and would
like to, please send your full name and address to: jane.shepley@endocrinology.org
The latest
issue of EFES news (Spring 2003) is now available on the EFES
website at: http://www.euro-endo.org/issue9.pdf.
EFES
Website
Please add the EFES website home page to your favourites http://www.euro-endo.org.
Navigate through the pages and give us your feedback and suggestions.
Please send any websites you would like to see added to EFES Links
to: jane.shepley@endocrinology.org
The EFES Executive
Committee sincerely appreciate your time and look forward to hearing
from you.
|
| |
| http://www.eje.org/ |
Advances
in diagnostic practices affect thyroid cancer incidence in France
L Leenhardt et al
Volume 150
Issue 2, pp 133-139
(http://www.eje.org/eje/150/eje1500133.htm)
During the
last 20 years France has seen an increase in thyroid cancer incidence
but no clear cause for this had been identified. The improvement
in medical, surgical and pathological diagnostic practices is
considered by many to be the most likely explanation for this,
and in their retrospective study Leenhardt and co-workers reinforce
this opinion.
Their study
served to elucidate two aspects of the rise in thyroid cancer
incidence: the changes in patient characteristics referred with
thyroid diseases and to analyse the trends in diagnostic practice
during the study period. Based on studies of arbitrarily selected
centres, an increase in ultrasonography scans and cytological
practices arose during the 20 years, although the number of patients
undergoing thyroid surgery remained constant. Statistical evidence
indicated that only changes in cytological practices were significantly
associated with the increase in thyroid cancer incidence.
|
| |
| http://www.euro-endo.org/congress.htm |
| 3-6
March 2004 |
German
Society of Endocrinology Symposium. Thyroid cancers: diagnosis
and therapy
Dresden, Germany
organiser: Prof G Vollmer
Web: http://www.medkongresse.de/dge2004
|
| 22-24
March 2004 |
23rd
Joint Meeting of the British Endocrine Societies with the
European Federation of Endocrine Societies
Brighton, UK
organiser: Feona Horrex, BioScientifica, Euro House, 22 Apex
Court, Woodlands, Bradley Stoke, Bristol BS32 4JT, UK
Phone: +44 1454 642212
Fax: +44 1454 642222
Email: feona.horrex@endocrinology.org
Web: http://www.endocrinology.org/SFE/BES2004/default.htm
|
| 3-7
September 2005 |
7th
European Congress of Endocrinology
Goteborg, Sweden
organiser: Congrex Goteborg AB, Ref. ECE 2005, PO Box 5078,
SE-402 22 Goteborg, Sweden
Tel: +46 31 7086000
Fax: +46 31 7086025
Email: ece2005@gbg.congrex.se
Web: http://www.ece2005.com
|
| 2007 |
8th
European Congress of Endocrinology
Budapest, Hungary
|
Please visit
the EFES conferences
pages for a full listing of events.
|
| |
| http://www.euro-endo.org/courses.htm |
| 7-9
May 2004 |
EFES
Regional Postgraduate Course in Clinical Endocrinology
Wroclaw, Poland
organiser: Prof Andrzej Milewicz, Department of Endocrinology
and Diabetology,
Wroclaw University of Medicine, Pasteura 4, PL-56-367 Wroclaw,
Poland
Phone: +48 71 3209603
Fax: +48 71 3282349
Email: milewicz@endo.am.wroc.pl
|
| 4-6
November 2004 |
3rd
EFES Czech-Hungarian-Polish-Romanian-Slovak Regional Postgraduate
Course in Endocrinology
Prague, Czech Republic
organisers: Prof Josef Marek, President of the Czech Endocrine
Society and Dr Michal Krsek, Chairman of the Local organising
Committee, 3rd Department of Internal Medicine, 1st Faculty
of Medicine, Charles University, U nemocnice 1, 128 08 Prague
2, Czech Republic
Fax: +420 2 24919780
Email: mkrse@lf1.cuni.cz
|
| 18-20
November 2004 |
12th
EFES Postgraduate Course in Clinical Endocrinology
Sitges, Spain
organisers: S Webb, Department of Endocrinology, Hospital
de Sant Pau, Padre Claret 167, 08025 Barcelona, Spain (Phone:
+34 93 2919042 Fax: +34 93 2919270 Email: swebb@santpau.es)
or M Puig-Domingo, Department of Endocrinology, Hospital
Clinic, Villaroel 171, 08036 Barcelona, Spain
Email:
mpuig@medicina.ub.es
|
|
| OTHER
INTERNATIONAL CONFERENCES |
top | next |
|
| |
| 2
March 2004 |
Environmental
and Human Effects of Endocrine Disrupting Chemicals
London, UK
Contact: SCI Conference Department, 14/15 Belgrave Square,
London SW1X 8PS, UK
Tel: +44 (0)20 75981563
Fax: +44 (0)20 72357743
Email: janette.niccolls@soci.org
Web: http://www.soci.org
|
| 18-20
March 2004 |
Joint
International Symposium on Calcitonin Gene-Related Peptide,
Amylin and Calcitonin. 4th Symposium on Adrenomedullin and
Proadrenomedullin N-20 Peptide
Zurich, Switzerland
Contact: Prof JA Fischer, Research Laboratory for Calcium
Metabolism, University of Zurich, Klinik Balgrist, Forchstrasse
340, CH-8008 Zurich, Switzerland
Tel: +41 1 3861651
Fax: +41 1 3861652
Email: fischerj@balgrist.unizh.ch
or wborn@balgrist.unizh.ch
Web: http://www.symposium2004.ch
|
| 14-17
April 2004 |
ESCI
2004: The 38th Annual Scientific Meeting of the European Society
for Clinical Investigation
Utrecht, The Netherlands
Contact: Utrecht University Conference Office, PO Box 80215,
3508 TC Utrecht, The Netherlands
Tel: +31 30 2532728
Fax: +31 30 2535851
E-mail: esci2004@fbu.uu.nl
Web: http://www.esci.eu.com/default.asp?page=meetings
|
| 18-22
April 2004 |
2nd
International GH-IGF Symposium
Queensland, Australia
Contact: Intermedia Convention and Event Management, 11/97
Castlemaine Street or PO Box 1280, Milton, Queensland 4064,
Australia
Tel: +61 7 38585597
Fax: +61 7 38585510
Email: grs2004@im.com.au
Web: http://www.ghigf2004.im.com.au
|
| 21-24
April 2004 |
5th
International Symposium on Women's Health and Menopause -
New Findings, New Strategies, Improved Quality of Life
Florence, Italy
Contact: MENO 2004, Fondazione Giovanni Lorenzini, Medical
Science Foundation, Via A. Appiani 7, 20121 Milan, Italy
Tel: +39 02 29006267
Fax: +39 02 29007018
Email: info@lorenzinifoundation.org
Web: http://www.lorenzinifoundation.org/menopause2004/index.html
|
| 16-19
June 2004 |
ENDO
2004: 86th Annual Meeting
New Orleans, LA, USA
Contact: Beverly Glover, Meetings, The Endocrine Society,
8401 Connecticut Avenue, Suite 900, Chevy Chase, MD 20815-5817,
USA
Tel: +1 301 9410220
Fax: +1 301 9410259
Email: bglover@endo-society.org
Web: http://www.endo-society.org
|
| 1-4
September 2004 |
International
Congress of Endocrinology
Lisbon, Portugal
Contact: International Society for Endocrinology, Department
of Chemical Endocrinology, 51-53 Bartholomew Close, London
EC1A 7BE, UK
Tel: +44 20 76064012
Fax: +44 20 77964676
Email: l.h.rees@mds.qmw.ac.uk
Web: http://www.jingo.com/ise/ice2004.htm
|
| 5-9
September 2004 |
40th
Annual Meeting of the European Association for the Study of
Diabetes
Munich, Germany
Contact: Rheindorfer Weg 3, D-40591 Düsseldorf, Germany
Tel: +49 211 7584690
Fax: +49 211 75846929
Email: annual-meeting@easd.org
Web: http://www.easd.org/customfiles/easd/40th/welcome.html
|
| 18-22
September 2004 |
30th
Annual Meeting of the European Thyroid Association
Istanbul, Turkey
Scientific Secretariat:
Dr. M.F. Erdogan, Dr. S. Güllü
The Society of Endocrinology & Metabolism of Turkey
Tel: +90 312 425 20 72
Fax: +90 312 425 20 98
E-mail: gurbuz.erdogan@semt.org.tr
, murat.erdogan@temd.org.tr
ETA 2004 Congress Secretariat (PCO)
Intra Istanbul Travel
Tel: +90 212 2191925
Fax: +90 212 2473085
E-mail: eta2004@intratravel.com
Web: http://www.eta2004.com
|
|
| |
| |
|
American Society of Clinical Oncology: international travel
grant
ASCO is pleased to announce the third year of the ASCO International
Travel Grants Program. ASCO will be awarding a limited number
of travel grants to individuals from countries with limited resources
that meet the eligibility requirements.
The monetary award is designed to cover expenses (coach airfare,
hotel, and meals) in order to attend the ASCO Annual Meeting in
New Orleans, Louisiana USA, June 2004. Grant recipients will also
receive complimentary meeting registration. Deadline: 4 February
2004
To review criteria for the 2004 International Travel Grants Program
and to apply, visit http://www.asco.org/ac/1,1003,_12-002596-00_18-0031005,00.asp
European
Chemical Industry Council (CEFIC): long-range research initiative
Part of CEFIC’s Research and Science programme,
this long-range research initiative’s mission is to identify
and fill gaps in our understanding of the hazards posed by chemicals
and to improve the methods available for assessing the associated
risks.
This award
will be presented to an individual for the proposal of a novel
interdisciplinary research project in the field of toxicology.
Project specifications
including budget details and an application form can be found
on the website: http://www.cefic-lri.org.
Deadline for applications is 1 March 2004
Jobs
and Grants Forum on the EFES website
Attention jobseekers! Post your details on the site.
Attention employers! Advertise jobs or search for suitable candidates
online.
Attention funders! Add your grant to the EFES forum.
Go to: http://www.euro-endo.org/jobs.htm
|
|
| |
|
Internet petition asks EU to repeal
clinical trials directive
European health-care researchers have launched a campaign calling
on the European Parliament and Commission to repeal their Directive
(EC/2001/20) on Good Clinical Practice. The internet petition
states that this ruling will mean that administrative costs of
clinical trials will be so high that those without pharmaceutical
backing, such as those cancer research trials involving generic
or widely available drugs, or (as in the case of screening) no
drugs at all will be too costly to carry out by charities or volunteers.
To see more, and sign the petition go to: http://www.saveeuropeanresearch.org
New resource
to help researchers move within Europe
An online Life Sciences Mobility Consultancy (LSMC) has been launched
by the European Molecular Biology Organisation (EMBO), with help
from the European Commission’s research Framework Programme.
The website is designed to provide researchers with access to
information on mobility within Europe, and includes searchable
information on grants, fellowships, awards, workshops and practical
courses in the life sciences, as well as listings of scientific
vacancies throughout Europe.
For further information see: http://mobility.embo.org
EU blueprint
of basic research
On 15 January European Research Commissioner Philippe Busquin
presented the communication “Europe and fundamental research”,
which provides an overview of basic research in the EU as compared
to other regions and calls for a debate on how to promote this
field.
In the last 20 years Europe’s basic research
has been overshadowed by mainly applied, market-orientated research.
Our fundamental science work now lags behind the US. Busquin noted
“Today’s research will turn into tomorrow’s
growth, competitiveness and better quality of life. The US has
understood this. Ours is a wake-up call: we need to act now to
reverse this situation and fill the gap”.
Future initiatives to redress the balance include
adopting the scheme of individual grants awarded to researchers
on the basis of excellence (that the US National Science Foundation
already do), so that individuals in any European country can compete
with all other researchers. The creation of a “European
Research Council” will also be one of the main themes of
the Union’s future action in the field of research.
A wider political debate on these actions will take place in the
coming months.
11.7
Million euro awarded for obesity and diabetes research
The FP6 programme has awarded 11.7 million euro to a large multicentre
project to identify novel drug targets to fight the obesity epidemic.
The researchers’ goal is to find four to five new genetic
targets which can be influenced by medicines to cure obesity and
obesity-related diseases, such as type 2 diabetes.
The grant is the largest the European Commission has ever given
to obesity and diabetes research and it is currently the largest
award in the area of chronic diseases (excluding cancer).
24 European institutions including three companies are participating
and it is being coordinated from Goteborg University.
Growth
hormone helps the heart
Researchers in Greece have found that supplementing ACE inhibitor
and diuretic treatment with growth hormone in patients with heart
failure leads to significant improvement in heart function and
better uptake of oxygen during exercise.
The team investigated whether the immune-modulating effect of
growth hormone was helpful in combating the abnormal immune reactions
that may contribute to chronic heart failure.
Growth
hormone therapy (4 IU every second day over 12 weeks) led to a
reduction in levels of various inflammatory factors and a rise
in an anti-inflammatory compound.
The
study, by Adamopoulos and colleagues, is published in December
15 issue of the European Heart Journal. For full text go to: http://www.harcourt-international.com/journals/euhj
|
|
| |
|
New work suggest melatonin could help hypertensive patients
Researchers from Harvard Medical School, Boston, and the Netherlands
Institute for Brain Research in Amsterdam have found that giving
nightly melatonin supplements to men with untreated hypertension
for three weeks lowered their nighttime blood pressure. Systolic
pressure reduced by an average of 6mmHg and diastolic by 4mmHg.
The
report, by Scheer and coworkers, is published in the February
issue of Hypertension. For full text go to: http://hyper.ahajournals.org
Possible
link between low testosterone levels and Alzheimer’s disease
Investigators at the National Institute of Aging, one of the US
National Institutes of Health, announced that results of their
prospective, observational study is the first to associate low
circulating levels of free testosterone with AD in men, years
before diagnosis.
The team found
that for every 50 percent increase in the free testosterone index,
there was about a 26 percent decrease in the risk of developing
AD. Testosterone levels also dropped more precipitously with age
in those men who later developed AD.
The authors
stressed that no causal relationship had been confirmed and that
it was unknown if hormonal therapy or any other intervention could
safely prevent AD.
The report,
by Resnick and coworkers, is published in the January 27 issue
of Neurology. For full text go to: http://www.neurology.org
|
|
| |
|
Finland
is first European market to approve Nebido
In December, a depot formulation of testosterone (Nebido) was
approved in Finland, it first European market for the treatment
of hypogonadism in men. Further approvals in Europe are expected
in the course of 2004.
Only four injections of Schering’s new testosterone formulation
are required over a year, patients currently have to have on average
22 injections.
New
long-acting LHRH implant drug application
Valera Pharmaceuticals submitted a new drug application to the
US Food and Drug Administration for Vantas, the company’s
long-acting Histrelin (LHRH) implant for treating prostate cancer.
Prostate cancer is the most prevalent form of cancer in American
men, and the market for LHRH therapeutics is expected to grow
to 1.4 billion USD in 2004.
|
| |
| http://www.euro-endo.org/discuss.htm |
|
Get involved!
The EFES website has a discussion forum
facility, please feel free to share your views, comments, and
interests with others. To join visit:
http://www.euro-endo.org/discuss.htm
|
| |
| |
| |
|